ADN tumoral circulant : aspects analytiques et intérêt dans la prise en charge des patients ayant un mélanome métastatique : Circulating tumour DNA: analytical aspects and clinical applications for metastatic melanoma patients

Abstract : The management of metastatic melanoma has evolved since the onset of treatments with BRAF inhibitors. In order to predict which patients are likely to respond to these treatments, the therapeutic strategy is now conditioned by the search for the activating mutations of the BRAF gene. Tumor genotyping is routinely performed from DNA extracted from tissue or cellular specimens from the primary tumor, metastases, or neoplastic effusions. Due to their invasiveness, these specimens are rarely repeated during the management. In addition, the analysis of the tumor material requires a pretreatment of the sample (formalin fixation, paraffin inclusion, preparation of tissue sections) and may take up to several weeks, making emergency treatment with BRAF inhibitors impossible. Circulating tumor DNA (ctDNA), released by cancer cells in the blood stream, appears as an alternative to tissue sampling. The pre-analytical conditions are now well defined, and several technological approaches can be used to demonstrate the desired molecular alterations. ctDNA is less affected by tumor heterogeneity, can be collected in a minimally invasive manner and analyzed rapidly. Furthermore, ctDNA can be repeatedly analyzed during follow-up, which makes it possible to envisage its use as a specific tumor marker, in order to monitor the response to the treatment and to detect treatment failure.
Document type :
Journal articles
Complete list of metadatas

Cited literature [14 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-01808416
Contributor : Elizabeth Bernardo <>
Submitted on : Tuesday, June 5, 2018 - 4:15:36 PM
Last modification on : Monday, May 20, 2019 - 3:32:01 PM

File

 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document

Identifiers

Collections

Citation

Guillaume Herbreteau, Audrey Vallée, Anne-Chantal Knol, Sandrine Théoleyre, Gaelle Quéreux, et al.. ADN tumoral circulant : aspects analytiques et intérêt dans la prise en charge des patients ayant un mélanome métastatique : Circulating tumour DNA: analytical aspects and clinical applications for metastatic melanoma patients. Annales de Biologie Clinique, John Libbey Eurotext, 2017, 75 (6), pp.619-630. ⟨10.1684/abc.2017.1305⟩. ⟨inserm-01808416⟩

Share

Metrics

Record views

138